Researchers have found that induced pluripotent stem cell--derived cardiomyocytes from a patient with arrhythmogenic cardiomyopathy recapitulate the reduced contractility and impaired desmosome assembly associated with this disease, providing a rapid and convenient platform for developing new treatments such as gene replacement therapy.
from Top Health News -- ScienceDaily https://ift.tt/3nSp4uy
No comments:
Post a Comment